These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 12444166

  • 1. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E, Wang L, Goodearl A, McDonald K, Qin S, O'Keefe T, Duong T, Smith T, Gutierrez-Ramos JC, Rottman JB, Coyle AJ, Hancock WW.
    J Immunol; 2002 Dec 01; 169(11):6546-53. PubMed ID: 12444166
    [Abstract] [Full Text] [Related]

  • 2. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I, Wang L, Wells AD, Ye Q, Han R, Dorf ME, Kuziel WA, Rollins BJ, Chen L, Hancock WW.
    J Immunol; 2003 Dec 15; 171(12):6929-35. PubMed ID: 14662900
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H, Sayegh MH, Najafian N.
    J Immunol; 2005 Jun 01; 174(11):6648-56. PubMed ID: 15905503
    [Abstract] [Full Text] [Related]

  • 4. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
    Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, Amaral J, Qin S, Rottman JB, Coyle AJ, Hancock WW.
    Nat Immunol; 2001 Jul 01; 2(7):591-6. PubMed ID: 11429542
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the B7 costimulatory pathway in allograft rejection.
    Pearson TC, Alexander DZ, Corbascio M, Hendrix R, Ritchie SC, Linsley PS, Faherty D, Larsen CP.
    Transplantation; 1997 May 27; 63(10):1463-9. PubMed ID: 9175811
    [Abstract] [Full Text] [Related]

  • 6. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H, Qiu F, Wang Y, Zeng Q, Liu C, Chen Y, Liang CL, Zhang Q, Han L, Dai Z.
    Front Immunol; 2019 May 27; 10():306. PubMed ID: 30863408
    [Abstract] [Full Text] [Related]

  • 7. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
    Dudler J, Li J, Pagnotta M, Pascual M, von Segesser LK, Vassalli G.
    Transplantation; 2006 Dec 27; 82(12):1733-7. PubMed ID: 17198268
    [Abstract] [Full Text] [Related]

  • 8. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, Najafian N, Yagita H, Azuma M, Turka LA, Sayegh MH.
    J Immunol; 2005 Mar 15; 174(6):3408-15. PubMed ID: 15749874
    [Abstract] [Full Text] [Related]

  • 9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.
    J Immunol; 2000 Sep 15; 165(6):3506-18. PubMed ID: 10975872
    [Abstract] [Full Text] [Related]

  • 10. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ.
    J Immunol; 2003 Feb 01; 170(3):1257-66. PubMed ID: 12538684
    [Abstract] [Full Text] [Related]

  • 11. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W, Demirci G, Strom TB, Li XC.
    Transplantation; 2003 Sep 27; 76(6):994-9. PubMed ID: 14508368
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.
    Smiley ST, Csizmadia V, Gao W, Turka LA, Hancock WW.
    Transplantation; 2000 Aug 15; 70(3):415-9. PubMed ID: 10949181
    [Abstract] [Full Text] [Related]

  • 13. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H.
    J Immunol; 2002 Nov 15; 169(10):5538-45. PubMed ID: 12421930
    [Abstract] [Full Text] [Related]

  • 14. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T, Okumura K, Yagita H, Azuma M.
    J Immunol; 2006 Nov 01; 177(9):5928-35. PubMed ID: 17056517
    [Abstract] [Full Text] [Related]

  • 15. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13967-72. PubMed ID: 8943044
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML.
    J Exp Med; 1998 Jul 06; 188(1):199-204. PubMed ID: 9653096
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2006 Aug 06; 47(8):3417-22. PubMed ID: 16877411
    [Abstract] [Full Text] [Related]

  • 18. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR.
    J Immunol; 2007 Sep 15; 179(6):3672-9. PubMed ID: 17785803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N, McAlister JC, Rogers NJ, Tan PH, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2003 Sep 15; 44(9):3899-905. PubMed ID: 12939307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.